Ethics

CDC Explains Its Stand On Controversial Third World AZT Study

Published in Medical Letter on the CDC and FDA, July 28th, 1997

The U.S. government's support of a study of the effects of the AIDS drug AZT (zidovudine) on preventing perinatal transmission of HIV is the subject of current ethical controversy.

The study subjects will be pregnant HIV positive women and the control group will be made up of pregnant uninfected women. The study will be conducted in Thailand and in the Ivory Coast (Cote d'Ivoire), Africa.

The Centers for Disease Control is one sponsor of the study. It recently addressed the issue, explaining its position in a question-and-answer format ("Questions and Answers: CDC Studies of AZT to Prevent Mother-to-Child HIV Transmission in Developing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1997-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry